Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04195178 · ClinicalTrials.gov registry record
Understanding the Cognition and Decision Making of Community Anesthesiologists
A clinical trial of Neuromuscular Blockade, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 154
- Enrollment target
- 1
- Study location
NCT04195178 is a study of Neuromuscular Blockade that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 154 participants, below the 11,815-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04195178, a study of Neuromuscular Blockade, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are interested in studying why experienced clinicians make specific decisions regarding the monitoring of patients' physiological states and why clinicians might make decisions that are contrary to current best practices or known evidence. More generally, the program objective is to refine and validate a novel methodology to delineate clinicians' decision-making strategies. More specifically, the investigators will study the decision to reverse neuromuscular blockade at the end of an anesthetic. This clinical decision will be studied in this project because: 1) it has been well documented that a substantial percentage of practitioners do not follow best practices; 2) the variables are relatively circumscribed and well described; and 3) it can be framed as a binary decision. The investigators propose to conduct an observational mixed-methods study developing and using clinical vignettes and cognitive interviews to better understand the decision-making approaches and preferences of clinically active anesthesia providers with regard to their decision-making during clinical anesthesia cases. After developing clinical vignettes and related questions, the investigators will first obtain detailed demographic and clinical practice variables from the participants via a survey. Participants will then review multiple vignettes that present different clinical situations that focus on decisions to reverse neuromuscular blockade and/or extubate the patient. Each participant will provide their decisions for each vignette. The investigators will then conduct an audiotaped interview, using cognitive task analysis methods, to ascertain the factors that played a role in these decisions.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2023-08-03 |
| Est. Completion | 2024-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04195178
The ClinicalTrials.gov registry entry for NCT04195178 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 11,815-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (99% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuromuscular Blockade appearing as the primary indexed condition, and to 0 interventions.
NCT04195178 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT04195178 about?
NCT04195178 is a clinical study titled "Understanding the Cognition and Decision Making of Community Anesthesiologists". The investigators are interested in studying why experienced clinicians make specific decisions regarding the monitoring of patients' physiological states and why clinicians might make decisions that are contrary to current best practices or known evidence. More generally, the program objective is t...
What is the current status of trial NCT04195178?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2023-08-03. Estimated completion is 2024-12-31.
What conditions does trial NCT04195178 study?
This clinical trial studies the following conditions: Neuromuscular Blockade.
Who is sponsoring clinical trial NCT04195178?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04195178 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromuscular Blockade
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
RECRUITING · Phase 4
-
Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison
RECRUITING
-
NMBA Reversal and Postoperative Urinary Retention
ACTIVE NOT RECRUITING
-
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
COMPLETED · Phase 4
-
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
COMPLETED
-
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.